Nicotine and vaping before cosmetic surgery: build one exposure and healing plan

Before cosmetic surgery, disclose every nicotine, tobacco, smoke, and aerosol source—including cigarettes, cigars, cannabis mixed with tobacco, vapes, pouches, gum, lozenges, patches, and prescription cessation products. They do not create identical exposures, but nicotine and combustion-related risks affect different parts of surgical and anesthesia planning. A safe plan uses the exact product and procedure; it does not rely on a universal internet stop date or tell someone to abandon prescribed cessation treatment without coordination.¹²³

The goal is not to shame a patient or catch them with a test. It is to make tissue-perfusion, airway, medication, withdrawal, and recovery decisions with accurate information.

Separate nicotine from smoke and aerosol

WHO links tobacco smoking with impaired heart and lung function, infection, and delayed or impaired wound healing after surgery.¹ Nicotine can narrow blood vessels; carbon monoxide and other combustion effects add separate oxygen-delivery and pulmonary concerns. A vape may remove combustion but still needs its nicotine, aerosol, and airway history documented.

Procedure design changes the consequence

Blood supply is especially important when surgery lifts, thins, advances, or transfers tissue. Flaps, grafts, long skin undermining, nipple-areola movement, face or neck lifting, abdominoplasty, breast reduction, implant exposure, and revision through scarred tissue can have different perfusion stakes. That does not make a short procedure risk-free or create one cutoff for every operation.

Ask the surgeon to explain:

• which tissue edges, flaps, grafts, or closure lines are most dependent on blood flow;
• how nicotine and smoking history change the operation or candidacy discussion;
• whether the plan changes incision, amount of undermining, combined procedures, or staging;
• what finding would postpone or cancel surgery;
• what wound signs trigger same-day review; and
• what the clinic’s written policy says about testing, cancellation, deposits, and rescheduling.

The answer should be procedure-specific. “Nicotine is bad” is not enough information to plan around it.

Timing should come from the operating team

WHO’s evidence summary reports lower complication risk among smokers who stopped around four weeks or more before surgery and notes that the optimum period varies with the outcome being considered.¹² A plastic surgeon may set a longer tobacco- or nicotine-free window for a tissue-sensitive operation, require confirmation after surgery, or treat nicotine-replacement therapy differently within a supported cessation plan.

Do not turn the WHO population summary into a personal clearance date. Ask the actual surgeon and anesthesia clinician for written instructions that distinguish:

• nicotine versus combustible or inhaled exposure;
• the last-use definition for each product;
• preoperative and postoperative windows;
• testing method and timing, if used;
• what happens after an unexpected positive result;
• prescription cessation medicines and nicotine replacement; and
• who manages cravings or withdrawal without substituting another undisclosed product.

A cotinine test is one piece of a policy

Cotinine is a nicotine metabolite. A clinic may use testing to check recent exposure, but a result does not reveal every route, exact dose, smoke exposure, or readiness for one procedure. Nicotine-replacement products can also affect the result.

Before paying a deposit, request the policy: analyte, specimen, collection date, threshold or laboratory interpretation, products included, confirmatory process, secondhand-exposure handling, prescription-replacement handling, cancellation terms, and who discusses a result. A home test or screenshot is not automatically equivalent to the clinic’s laboratory process.

Testing should not replace history. A truthful exposure record helps the team plan for airway symptoms, carbon-monoxide exposure, withdrawal, pain and anxiety, healing, and the home environment.

Coordinate cessation support instead of improvising

WHO notes that structured behavioral and pharmacologic support can help smoking cessation around surgery.² A nicotine patch or gum may be part of an evidence-based plan in general care, while an individual plastic surgeon may have specific perioperative rules for a chosen operation. That apparent tension is exactly why the surgeon, anesthesia team, and prescribing or cessation clinician should reconcile the plan.

Do not switch from cigarettes to vaping, pouches, or unverified “nicotine-free” products solely to pass a surgery rule. The new route may change rather than erase the relevant exposure, and a hidden substitution removes information the team needs.

Recovery exposure matters too

A preoperative negative test does not protect tissue during recovery. Clarify the postoperative window, household smoke plan, transportation, stress and withdrawal support, pain control, alcohol and other substance instructions, and the contact route before any relapse or unexpected exposure.

If a lapse occurs, tell the operating team rather than calculating whether it “counts.” The clinical and scheduling response may depend on product, amount, timing, procedure, and healing stage.

ASPS materials emphasize that plastic-surgery planning should account for nicotine and smoking because blood flow and wound healing are central to many procedures.³⁴ The practical response is a complete handoff, not a moral judgment.

The useful take-home is one reconciled exposure and healing plan shared by the surgeon and any prescribing clinician: what is used, what must change, when, how cessation support and testing fit, and who owns each instruction. Completeness is the safety feature; shame and concealment are not.